Afya Announces Changes to Its Board of Directors

Afya Limited (Nasdaq: AFYA; B3: A2FY34), a prominent medical education provider in Brazil, has announced significant changes to its Board of Directors following the planned resignation of Mrs. Maria Tereza Azevedo. Effective December 31, 2025, Azevedo’s departure will conclude her time on the board, and Afya has expressed gratitude for her dedication and valuable contributions, wishing her success in her future endeavors.

Currently, Afya's Board is comprised of diverse members, including co-chairmen Nicolau Carvalho Esteves, representing the Esteves family, and Kay Krafft, representing Bertelsmann SE&Co. KGaA. The board includes additional members from both Bertelsmann and the Esteves family, alongside four independent directors. This structure enriches the board’s decision-making capabilities with a broad range of skills and experience, supporting Afya’s strategic goals and initiatives. The full board currently features:

- Nicolau Carvalho Esteves, Co-Chairman - Kay Krafft, Co-Chairman - Benedikt Dalkmann, Director - Christina Krebs, Director - Renato Tavares Esteves, Director - João Paulo Seibel de Faria, Independent Director - Vanessa Claro Lopes, Independent Director - Miguel Filisbino Pereira de Paula, Independent Director - Marcelo Ken Suhara, Independent Director

Afya Limited is recognized for its expansive medical educational offerings, which include medical school programs, residency preparation, and ongoing medical education. The company is dedicated to empowering students and physicians and transforming their educational ambitions into successful career experiences. With Azevedo’s upcoming resignation, Afya is poised to continue its growth and innovation in the medical education sector.

Afya Limited's recent announcement regarding the resignation of board member Maria Tereza Azevedo offers potential insights into the company's strategic direction and market positioning. Azevedo's departure, effective December 31, 2025, is coupled with a diverse and well-structured board that includes both family and independent directors, which indicates a blend of strategic continuity and modern governance. It's crucial for investors to monitor how this leadership change may influence company decisions moving forward.

Afya operates in Brazil's burgeoning medical education and healthcare sector, a market projected for substantial growth, driven by increasing healthcare demands and advancements in medical education. The composition of the board, featuring representatives from significant stakeholders like Bertelsmann SE&Co. KGaA and the Esteves family, suggests a strong commitment to align the company’s objectives with the interests of its investors. The active involvement of independent directors can also enhance objectivity in decision-making processes.

From an investment perspective, the leadership's ability to navigate changes and maintain momentum amid transitions is critical. Potential investors should assess how the board plans to capitalize on ongoing trends in medical education and healthcare provision, such as digital integration and tailored educational pathways for medical professionals.

Moreover, Afya's comprehensive approach—from student recruitment to continuing education and medical practice solutions—positions it well to capture market share. Investors may wish to evaluate the company’s adaptability and operational resilience following the board changes.

In summary, Afya's board change is a strategic moment worthy of attention. Long-term investors should analyze how the company leverages its board's expertise to address upcoming challenges and opportunities within Brazil's healthcare landscape, and watch for any changes in strategic initiatives that may arise in response to this leadership transition.